126
Views
2
CrossRef citations to date
0
Altmetric
Letters

Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis

, , , , , , & show all
Pages 242-243 | Accepted 03 Jan 2012, Published online: 09 Mar 2012
 

Acknowledgement

The study has been financially supported by Roche Pharma AG Germany.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 171.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.